FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126202335> ?p ?o ?g. }

• W3126202335 endingPage "107405" @default.
• W3126202335 startingPage "107405" @default.
• W3126202335 abstract "Few studies on the immunoglobulin E (IgE) immune response in chronic hepatitis C have been reported. In this study, we tested the antigenicity of commercial recombinant hepatitis C virus (HCV) core and nonstructural protein NS3, NS4, and NS5 antigens and the IgE immune response to these antigens in chronic hepatitis C patients before and after antiviral treatment with pegylated interferon (IFN)-α plus ribavirin for 12 weeks. The effects of antiviral treatment were investigated in 20 out of 35 participants. We developed amplified immunoassays using these antigens and IgG-depleted patient sera. Seropositivity for IgE antibodies was determined, and serum IgE and cytokine levels were measured. Anti-core, anti-NS3, and anti-NS4 IgE antibodies were observed in most patients, whereas anti-NS5 antibodies were less prevalent. Antiviral treatment decreased the production of anti-core, anti-NS3, and anti-NS4 IgE antibodies, but not anti-NS5 IgE antibodies. A significant decrease in the anti-NS3 and anti-NS4 IgE antibody levels was observed in patients who presented with an early sustained virological response, but no effects on anti-core and anti-NS5 IgE antibodies was observed. The serum levels of IFN-γ, interleukin (IL)-2, IL-6, tumor necrosis factor-α, and IL-10, but not IL-4, were similar between patients before and after antiviral therapy. Thus, the immune response of IgE antibodies to HCV antigens was comparable to that of anti-HCV IgG antibodies. The usefulness of anti-NS3 IgE antibodies in diagnosing occult hepatitis C and monitoring antiviral treatment with directly acting antiviral medication must be investigated in future studies." @default.
• W3126202335 created "2021-02-15" @default.
• W3126202335 creator A5016349511 @default.
• W3126202335 creator A5027780789 @default.
• W3126202335 creator A5060819911 @default.
• W3126202335 creator A5068983030 @default.
• W3126202335 creator A5070193955 @default.
• W3126202335 creator A5075465929 @default.
• W3126202335 date "2021-04-01" @default.
• W3126202335 modified "2023-10-17" @default.
• W3126202335 title "IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment" @default.
• W3126202335 cites W1621957955 @default.
• W3126202335 cites W1980953214 @default.
• W3126202335 cites W1988164578 @default.
• W3126202335 cites W1989647272 @default.
• W3126202335 cites W2007694385 @default.
• W3126202335 cites W2022057836 @default.
• W3126202335 cites W2042063943 @default.
• W3126202335 cites W2069542935 @default.
• W3126202335 cites W2094174828 @default.
• W3126202335 cites W2119885012 @default.
• W3126202335 cites W2146322888 @default.
• W3126202335 cites W2166087961 @default.
• W3126202335 cites W2757200055 @default.
• W3126202335 cites W2771528767 @default.
• W3126202335 cites W2919578592 @default.
• W3126202335 cites W2960053108 @default.
• W3126202335 cites W2992772421 @default.
• W3126202335 cites W3015631374 @default.
• W3126202335 doi "https://doi.org/10.1016/j.intimp.2021.107405" @default.
• W3126202335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33529909" @default.
• W3126202335 hasPublicationYear "2021" @default.
• W3126202335 type Work @default.
• W3126202335 sameAs 3126202335 @default.
• W3126202335 citedByCount "1" @default.
• W3126202335 countsByYear W31262023352023 @default.
• W3126202335 crossrefType "journal-article" @default.
• W3126202335 hasAuthorship W3126202335A5016349511 @default.
• W3126202335 hasAuthorship W3126202335A5027780789 @default.
• W3126202335 hasAuthorship W3126202335A5060819911 @default.
• W3126202335 hasAuthorship W3126202335A5068983030 @default.
• W3126202335 hasAuthorship W3126202335A5070193955 @default.
• W3126202335 hasAuthorship W3126202335A5075465929 @default.
• W3126202335 hasConcept C132379496 @default.
• W3126202335 hasConcept C141105273 @default.
• W3126202335 hasConcept C147483822 @default.
• W3126202335 hasConcept C159047783 @default.
• W3126202335 hasConcept C159654299 @default.
• W3126202335 hasConcept C203014093 @default.
• W3126202335 hasConcept C2522874641 @default.
• W3126202335 hasConcept C2776408679 @default.
• W3126202335 hasConcept C2780040827 @default.
• W3126202335 hasConcept C71924100 @default.
• W3126202335 hasConcept C8891405 @default.
• W3126202335 hasConceptScore W3126202335C132379496 @default.
• W3126202335 hasConceptScore W3126202335C141105273 @default.
• W3126202335 hasConceptScore W3126202335C147483822 @default.
• W3126202335 hasConceptScore W3126202335C159047783 @default.
• W3126202335 hasConceptScore W3126202335C159654299 @default.
• W3126202335 hasConceptScore W3126202335C203014093 @default.
• W3126202335 hasConceptScore W3126202335C2522874641 @default.
• W3126202335 hasConceptScore W3126202335C2776408679 @default.
• W3126202335 hasConceptScore W3126202335C2780040827 @default.
• W3126202335 hasConceptScore W3126202335C71924100 @default.
• W3126202335 hasConceptScore W3126202335C8891405 @default.
• W3126202335 hasFunder F4320322025 @default.
• W3126202335 hasLocation W31262023351 @default.
• W3126202335 hasOpenAccess W3126202335 @default.
• W3126202335 hasPrimaryLocation W31262023351 @default.
• W3126202335 hasRelatedWork W2029008013 @default.
• W3126202335 hasRelatedWork W2034841682 @default.
• W3126202335 hasRelatedWork W2096288449 @default.
• W3126202335 hasRelatedWork W2155354381 @default.
• W3126202335 hasRelatedWork W2220102944 @default.
• W3126202335 hasRelatedWork W2442510806 @default.
• W3126202335 hasRelatedWork W2914965217 @default.
• W3126202335 hasRelatedWork W3183136266 @default.
• W3126202335 hasRelatedWork W4235919785 @default.
• W3126202335 hasRelatedWork W2914046183 @default.
• W3126202335 hasVolume "93" @default.
• W3126202335 isParatext "false" @default.
• W3126202335 isRetracted "false" @default.
• W3126202335 magId "3126202335" @default.
• W3126202335 workType "article" @default.